CDISC Membership
Forecast Overview
- NAICS
- 813920
- Performance end
- 11/2025
The CDISC standard serves as the foundational data standard for FDA's daily operations in conducting clinical and non-clinical reviews. Our continued participation in CDISC discussions and standard development ensures that FDA maintains its position as the leading global regulatory health authority in establishing critical data standards. Without proper data standards like CDISC, FDA cannot effectively modernize the regulatory review process. The annual membership renewal cost ( per year) represents a minimal investment that enables FDA to exercise leadership in the global regulatory review arena.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31